← Eichor
Condition: Pet Tracer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pet Tracer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Phase 3 · 1 location(s) · HTA Co., Ltd. · NCT0675408561Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)
Phase 1/Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT0645535868Ga-NYM096 PET/CT in Various Kinds of Cancer
NA · 1 location(s) · Peking Union Medical College Hospital · NCT07144748Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3 · 15 location(s) · SOFIE · NCT07217717Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomograp
EARLY_Phase 1 · 1 location(s) · MODAG GmbH · NCT07617688FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer,
Phase 2 · 6 location(s) · Northwestern University · NCT06244004First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
Phase 1/Phase 2 · 1 location(s) · David Wilson · NCT0537427868Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT07273188Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer
Phase N/A · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06916338Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan
Phase 2 · 9 location(s) · Convergent Therapeutics · NCT06549465Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
Phase 2/Phase 3 · 9 location(s) · Cancer Research Antwerp · NCT06282588Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07487883PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Phase 1 · 1 location(s) · Karolinska University Hospital · NCT05172310Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
Phase 1/Phase 2 · 1 location(s) · University Medical Center Groningen · NCT06616142[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
Phase 2 · 1 location(s) · Asan Medical Center · NCT07314073Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
Phase N/A · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06916624Evaluation of Kidney Fibrosis Via FAPI PET/CT
NA · 1 location(s) · Medical University of Vienna · NCT07712679A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tum
Phase 1 · 2 location(s) · GE Healthcare · NCT05629689PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.
Phase 4 · 1 location(s) · Stony Brook University · NCT07095205A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT I
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07448623PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects
Phase 1 · 1 location(s) · Intra-Cellular Therapies, Inc. · NCT06299410Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
Phase 2 · 9 location(s) · Curasight · NCT06474806A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
Phase 2 · 2 location(s) · Chengdu Zenitar Biomedical Technology Co., Ltd · NCT06457425CXCR4-targeted PET/CT Imaging in Hematological Malignancies
NA · 1 location(s) · Zhongnan Hospital · NCT05255926Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Disease
Phase 4 · 1 location(s) · Vanderbilt University Medical Center · NCT05357612PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
Phase 2 · 1 location(s) · Jinling Hospital, China · NCT07175480A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Eval
NA · 1 location(s) · Xijing Hospital · NCT06769893PET-imaging of Two Vartumabs in Patients With Solid Tumors
EARLY_Phase 1 · 1 location(s) · Var2 Pharmaceuticals · NCT06645808PSMA PET Combined With MRI for the Detection of PCa
Phase 3 · 18 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07052214A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Phase 2 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06335888
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.